
Sign up to save your podcasts
Or


Dr. Johnathan Canton is an Assistant Professor at the University of Calgary, where his lab uses advanced microscopy techniques to study dendritic cells, macrophages, and innate immunity. He talks about his career journey from studying tropical parasites to investigating phagocytes. He also discusses using advanced microscopy techniques, studying the mechanisms of dendritic cell cross-presentation, and running a farm in Belize. (35:55)
Armored CAR T Cells – A CRISPR knock-in strategy can engineer CAR T cells that secrete proinflammatory cytokines directly within a tumor without causing toxicity. (2:15)
Immune Invasion in Lung Cancer – Organoid immune co-cultures enable identifying immune evasion at subclonal resolution. (7:55)
Chromatin Remodeling in Chronic Inflammation – Researchers identified a mechanism that separates the chronic and acute inflammation responses. (19:00)
Reversing CD8⁺ T Cell Dysfunction – Scientists identified IL-27 as a tractable immunotherapeutic target in chronic hepatitis B virus infection. (25:40)
Never miss updates about new episodes.
By The Immunology Podcast4.4
4040 ratings
Dr. Johnathan Canton is an Assistant Professor at the University of Calgary, where his lab uses advanced microscopy techniques to study dendritic cells, macrophages, and innate immunity. He talks about his career journey from studying tropical parasites to investigating phagocytes. He also discusses using advanced microscopy techniques, studying the mechanisms of dendritic cell cross-presentation, and running a farm in Belize. (35:55)
Armored CAR T Cells – A CRISPR knock-in strategy can engineer CAR T cells that secrete proinflammatory cytokines directly within a tumor without causing toxicity. (2:15)
Immune Invasion in Lung Cancer – Organoid immune co-cultures enable identifying immune evasion at subclonal resolution. (7:55)
Chromatin Remodeling in Chronic Inflammation – Researchers identified a mechanism that separates the chronic and acute inflammation responses. (19:00)
Reversing CD8⁺ T Cell Dysfunction – Scientists identified IL-27 as a tractable immunotherapeutic target in chronic hepatitis B virus infection. (25:40)
Never miss updates about new episodes.

32,246 Listeners

7,913 Listeners

321 Listeners

2,053 Listeners

504 Listeners

756 Listeners

818 Listeners

281 Listeners

9,167 Listeners

337 Listeners

2,592 Listeners

203 Listeners

551 Listeners

5,576 Listeners

13 Listeners